Colorectal cancer: Adding selective internal radiotherapy to chemotherapy boosts survival

Adding selective internal radiotherapy to standard first-line mFOLFOX6 chemotherapy in patients with liver-only or liver-dominant metastatic colorectal cancer led to notable increases in median overall survival for patients with right-sided primary tumours, new research reveals.
Medical News Today